| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/16/2002 | US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis |
| 05/16/2002 | US20020058735 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith |
| 05/16/2002 | US20020058672 Use of benzoylalkyl-1,2,3,6-tetrahydropyridines |
| 05/16/2002 | US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception |
| 05/16/2002 | US20020058629 S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives |
| 05/16/2002 | CA2426716A1 Acid derivatives useful as serine protease inhibitors |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204641A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 05/15/2002 | EP1204640A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349503A Renin ihibitors |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1084744C N-substituted azaheterocyclic compounds |
| 05/15/2002 | CN1084743C 毒蕈碱拮抗剂 Muscarinic antagonist |
| 05/14/2002 | US6388122 Tryptase inhibitor and novel guanidino derivatives |
| 05/14/2002 | US6388118 Process for the preparation of cyclopentadienyl compounds and compounds obtained therefrom |
| 05/14/2002 | US6388083 Process for the synthesis of (2S)-phenyl-3-piperidone |
| 05/14/2002 | US6388076 Antiproliferative agents; skin disorders; osteoporosis |
| 05/14/2002 | US6388072 Tetraalkyl substituted piperidine substituted on the n-atom with o-e-oh group (e= alkylene or phenylene or cycloaliphatic derivatives) are used for stabilizing polyolefins and automotive coating against heat, oxidation |
| 05/14/2002 | US6387930 Antiarthritic agents; antiallergens; skin disorders; inflammatory bowel disorders |
| 05/14/2002 | US6387897 Preferentially substituted calcium channel blockers |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | WO2002036547A1 Cyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 05/10/2002 | WO2002036123A2 New treatments for restless legs syndrome |
| 05/10/2002 | WO2002028833A8 Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine |
| 05/10/2002 | WO2001089498A3 USE OF (+)-α -(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS |
| 05/10/2002 | CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 05/10/2002 | CA2421705A1 New treatments for restless legs syndrome |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis. |
| 05/09/2002 | US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/09/2002 | US20020055521 Analogs of cocaine |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202969A2 Biphenyl derivatives, production thereof and use as medicines |
| 05/08/2002 | EP1202968A2 Antibacterial agents |
| 05/08/2002 | EP1202967A2 Sulfuric acid mono-[3-((1-(2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl)-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 05/08/2002 | EP1202966A1 Piperidine alcohols |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202718A2 Substituted guanidines for the treatment of cancer and pain |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists |
| 05/08/2002 | CN1348371A Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
| 05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/08/2002 | CN1084329C Benzyl piepridine derivative |
| 05/07/2002 | US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 05/07/2002 | US6384227 Heating the compound in an aqueous medium which includes an organic cosolvent, and recovering the product that is precipitated, on cooling |
| 05/07/2002 | US6384080 Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase |
| 05/07/2002 | US6384056 Cognition activators and nerve and vision disorders |
| 05/07/2002 | US6384035 Heterocycles useful in the treatment of benign prostatic hyperplasia |
| 05/07/2002 | US6384028 Treatment of cardiovascular disorders, anticoagulants and valve replacement |
| 05/07/2002 | CA2145000C Compounds which are selective antagonists of the human nk3 receptor and their use as medicinal products and diagnostic tools |
| 05/05/2002 | WO2002042270A1 Substituted benzene derivatives or salts thereof |
| 05/02/2002 | WO2002034719A1 Nitrogenous saturated heterocycle compounds |
| 05/02/2002 | WO2002034718A1 Amide derivatives as nmda receptor antagonists |
| 05/02/2002 | WO2002000574A3 Catalysis using phosphine oxide and sulfoxide compounds |
| 05/02/2002 | WO2001085675A3 Fluorous tagging compounds and their use |
| 05/02/2002 | WO2001042207A3 Novel methods for the treatment and prevention of ileus |
| 05/02/2002 | US20020052514 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth |
| 05/02/2002 | US20020052510 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 05/02/2002 | US20020052506 From hydroxyl-protected oxime intermediates, includes formation of a lactam which is reduced to the hexitol; chemical intermediates to D-dideoxygalacto-nojirimycins |
| 05/02/2002 | US20020052505 Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines |
| 05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052383 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; treatment of a variety of metabolic, feeding, and sexual disorders including obesity. |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052372 Using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/02/2002 | US20020052007 Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| 05/02/2002 | US20020052003 Composition for use in the adhesion of particle to surfaces |
| 05/02/2002 | EP1201649A1 Glucocorticoid receptor modulators |
| 05/02/2002 | EP1200432A1 Amido spiropiperidines promote the release of growth hormone |
| 05/02/2002 | EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 05/02/2002 | EP1200405A1 Benzenamine derivatives as anti-coagulants |
| 05/02/2002 | EP1200397A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 05/02/2002 | EP0885004B1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
| 05/02/2002 | EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1346828A Dicyclic aromatic compound and use thereof in human or animal medicine and cosmetic process |
| 05/01/2002 | CN1346825A Process for preparing 2,2,6,6-tetramethyl-4-piperidylamine compounds as intermediate of optical stabilizer |
| 05/01/2002 | CN1083835C Process for preparation of 3,3,5-trichloroglutarimide |
| 05/01/2002 | CN1083834C Nipecotic acid derivs. as antithrombic compounds |
| 04/30/2002 | US6380389 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith |
| 04/30/2002 | US6380286 For stabilizing an organic material which is sensitive to oxidative, thermal or light-induced degradation |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380243 Including human cytomegalovirus, herpes simplex viruses, epstein-barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and kaposi herpesvirus. |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380220 Therapy of neurodegenerative diseases and neuronal injuries which are casued by ischemia, trauma or massive hemorrhages |
| 04/30/2002 | US6380216 Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders |